E Fund Management »

Cytokinetics shares owned by E Fund Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 239 65.91

More positions owned by E Fund Management

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
PDD Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
Apple (AAPL)
Yum China Holdings (YUMC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Newmont Mining Corporation (NEM)
Broadcom (AVGO)
H World Group Sponsored Ads (HTHT)
Meta Platforms Cl A (META)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for E Fund Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics